---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-043808"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2026-09-23T11:45:18+00:00"
generated_at: "2026-09-23T11:50:07.632475+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "medium"
source: SEC EDGAR
---

# Lantern Pharma to present Open-Medicine AI growth plan in live webinar today

## Summary
- Webinar at 12:30 PM ET led by CEO Panna Sharma covering OMAI market, roadmap, economics, benchmarks, partnerships.
- OMAI launched as withZeta.ai in April 2026 for rare cancers; ZetaOmics module added July 2026 for early-access users.
- Platform monetized via subscription and enterprise licensing to biopharma, research institutions, and drug developers.
- Session to include live demo, user feedback, key milestones, and shareholder-value discussion; replay available post-event.

## SEC filing metadata
- accession: 0001493152-26-043808
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2026-09-23T11:45:18+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315226043808/0001493152-26-043808-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315226043808/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-043808
- JSON: https://secwatch.observer/filing/0001493152-26-043808.json
- Plain text: https://secwatch.observer/filing/0001493152-26-043808.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.